Antipodes Partners LTD Abbott Laboratories Transaction History
Antipodes Partners LTD
- $3 Billion
- Q2 2025
A detailed history of Antipodes Partners LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Antipodes Partners LTD holds 741 shares of ABT stock, worth $97,019. This represents 0.0% of its overall portfolio holdings.
Number of Shares
741
Previous 1,270
41.65%
Holding current value
$97,019
Previous $168,000
40.48%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,585Shares Held
1.38BCall Options Held
9.73MPut Options Held
8.88M-
Vanguard Group Inc Valley Forge, PA170MShares$22.2 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.2 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.75 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.64 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $229B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...